Pfizer Inc mentioned on Tuesday it’ll begin a big research to take a look at its COVID-19 vaccine in kids beneath 12 and chosen a dosing regime for the trial. The research will enroll up to 4,500 kids at greater than 90 scientific websites in the United States, Finland, Poland and Spain, the corporate mentioned.
Pfizer’s vaccine has been licensed to be used in kids as younger as 12 in Europe, the United States and Canada. The firm mentioned it has chosen a dose of 10 micrograms in kids between 5 and 11 years of age and three micrograms between for infants in age-group of 6 months to 5.
Inoculating kids and younger folks is taken into account a crucial step towards reaching “herd immunity” and taming the COVID-19 pandemic.
Read all of the Latest News, Breaking News and Coronavirus News right here
